These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23642012)

  • 21. Treatment with cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism.
    López V; Toledo R; Sola E; Gutiérrez C; Sujan S; Rodríguez MA; Cabello M; Burgos D; González Molina M; Hernández D
    Transplant Proc; 2009; 41(6):2394-5. PubMed ID: 19715930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan.
    Iseki K
    Expert Opin Pharmacother; 2008 Mar; 9(4):601-10. PubMed ID: 18312161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cinacalcet treatment in dialysis patients with secondary hyperparathyroidism: effects and open issues.
    Drüeke TB
    Ther Apher Dial; 2008 Oct; 12 Suppl 1():S2-12. PubMed ID: 19032522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
    Parfrey PS; Drüeke TB; Block GA; Correa-Rotter R; Floege J; Herzog CA; London GM; Mahaffey KW; Moe SM; Wheeler DC; Kubo Y; Dehmel B; Goodman WG; Chertow GM;
    Clin J Am Soc Nephrol; 2015 May; 10(5):791-9. PubMed ID: 25710802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients--results of the Austrian cohort of the ECHO study.
    Zitt E; Jäger C; Rosenkranz AR; Eigner M; Kodras K; Kovarik J; Graf H; Pétavy F; Horn S; Watschinger B
    Wien Klin Wochenschr; 2011 Jan; 123(1-2):45-52. PubMed ID: 21253777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cinacalcet on bone mineral density and bone markers in hemodialysis patients with secondary hyperparathyroidism.
    Tsuruta Y; Okano K; Kikuchi K; Tsuruta Y; Akiba T; Nitta K
    Clin Exp Nephrol; 2013 Feb; 17(1):120-6. PubMed ID: 22833360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism.
    Ureña-Torres P; Bridges I; Christiano C; Cournoyer SH; Cooper K; Farouk M; Kopyt NP; Rodriguez M; Zehnder D; Covic A
    Nephrol Dial Transplant; 2013 May; 28(5):1241-54. PubMed ID: 23328710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utilization of cinacalcet in hypercalcemic conditions.
    Messa P; Alfieri C; Brezzi B
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):517-28. PubMed ID: 21361849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis.
    Torregrosa JV; Bergua C; Martinez de Osaba MJ; Oppenheimer F; Campistol JM
    Transplant Proc; 2009; 41(6):2396-8. PubMed ID: 19715931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term cinacalcet HCl treatment improved bone metabolism in Japanese hemodialysis patients with secondary hyperparathyroidism.
    Shigematsu T; Akizawa T; Uchida E; Tsukamoto Y; Iwasaki M; Koshikawa S;
    Am J Nephrol; 2009; 29(3):230-6. PubMed ID: 18797166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parathyroidectomy in the calcimimetic era.
    Elder GJ
    Nephrology (Carlton); 2005 Oct; 10(5):511-5. PubMed ID: 16221104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative hypocalcemia after parathyroidectomy for renal hyperparathyroidism in the era of cinacalcet.
    Meyers MO; Russell CP; Ollila DW; Yeh JJ; Kim HJ; Calvo BF
    Am Surg; 2009 Sep; 75(9):843-7. PubMed ID: 19774959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Cinacalcet and Parathyroidectomy on Blood Pressure in Maintenance Hemodialysis Patients with Secondary Hyperparathyroidism.
    Wang M; Wen D; Zhang W; Chen W; Tao Y; Fan C; Huang B; Chen J; Wang H; Zhang M
    Iran J Kidney Dis; 2022 Mar; 16(2):135-146. PubMed ID: 35489082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cinacalcet may reduce arterial stiffness in patients with chronic renal disease and secondary hyperparathyroidism - results of a small-scale, prospective, observational study.
    Bonet J; Bayés B; Fernández-Crespo P; Casals M; López-Ayerbe J; Romero R
    Clin Nephrol; 2011 Mar; 75(3):181-7. PubMed ID: 21329627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreasing Surgical Management of Secondary Hyperparathyroidism in the United States.
    Fligor SC; Li C; Hamaguchi R; William J; James BC
    J Surg Res; 2021 Aug; 264():444-453. PubMed ID: 33848844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D study.
    Fukagawa M; Fukuma S; Onishi Y; Yamaguchi T; Hasegawa T; Akizawa T; Kurokawa K; Fukuhara S
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1473-80. PubMed ID: 22822017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cinacalcet: a new treatment for secondary hyperparathyroidism in patients receiving hemodialysis.
    Byrnes CA; Shepler BM
    Pharmacotherapy; 2005 May; 25(5):709-16. PubMed ID: 15899733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Mealing S; Roome C; Snaith A; D'Souza R; Welch K; Stein K
    Health Technol Assess; 2007 May; 11(18):iii, xi-xiii, 1-167. PubMed ID: 17462168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism.
    Ruderman I; Smith ER; Toussaint ND; Hewitson TD; Holt SG
    BMC Nephrol; 2018 May; 19(1):113. PubMed ID: 29764395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Secondary Hyperparathyroidism Treatment on Improvement in Anemia: Results from the MBD-5D Study.
    Tanaka M; Yoshida K; Fukuma S; Ito K; Matsushita K; Fukagawa M; Fukuhara S; Akizawa T
    PLoS One; 2016; 11(10):e0164865. PubMed ID: 27764168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.